Home › Companies › PROCEPT BioRobotics Corporation › 2025-2026

PROCEPT BioRobotics Corporation 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and PROCEPT BioRobotics Corporation’s Form 8-K, filed 2026-06-10 (Item 5.07 on EDGAR). Page generated 02 October 2026.

5Reported items
272Asset managers
1,292Fund votes
2026-06-09Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore PROCEPT BioRobotics Corporation in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by PROCEPT BioRobotics Corporation

These tallies are PROCEPT BioRobotics Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-10 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

PROCEPT BioRobotics Corporation — official shareholder meeting results, meeting held 2026-06-09
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Antal Desai	28,444,121	--	--	8,511,185	10,418,057	Majority: yes
Elect Director: Mary Garrett	29,150,610	--	--	7,804,696	10,418,057	Majority: yes
Elect Director: Frederic Moll, M.D.	36,455,610	--	--	499,696	10,418,057	Majority: yes
Proposal 3 in the Proxy Statement, a proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, was approved by the following vote:	26,984,867	--	45,735	9,924,704	10,418,057	Majority: yes

Source: PROCEPT BioRobotics Corporation, Form 8-K, filed with the SEC on 2026-06-10 — read the filing on EDGAR.

How asset managers voted at the PROCEPT BioRobotics Corporation 2025-2026 meeting

Each item below shows how the 272 asset managers that disclosed a PROCEPT BioRobotics Corporation vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of PROCEPT BioRobotics Corporation’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 11 wordings of this item as funds reported it.

73% Majority: yes · of votes cast

FOR 73%WITHHELD 27%

FOR: 26,984,867WITHHELD: 9,924,704

PROCEPT BioRobotics Corporation’s own tally for this item (“Proposal 3 in the Proxy Statement, a proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, was approved by the following vote:”): 26,984,867 for, 9,924,704 withheld, per its Form 8-K filed 2026-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 56,897,000 outstanding shares: 47.4% for, 17% withheld (65% of the company cast a for/withheld vote).

The 272 asset managers below cast 71% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 71%AGAINST 29%

FOR: 70.9%AGAINST: 28.9%ABSTAIN: 0.0%NOT VOTED: 0.2%UNKNOWN: 0.0%

Largest asset managers voting on “Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers.” at PROCEPT BioRobotics Corporation, 2025-2026
Asset manager	For	Against	Vote
T. Rowe Price	6,200,494	155,736	For
Vanguard	5,281,532	12,315	For
BNP Paribas Asset Management Holding S.A.	0	3,013,555	Against
BlackRock	2,594,405	171,987	For
MACKENZIE FINANCIAL CORP	1,716,294	0	For
Chicago Capital, LLC	1,436,659	0	For
Charles Schwab	915,465	0	For
Artisan	795,185	0	For
MIROVA	0	729,281	Against
Wellington	635,331	0	For
Janus Henderson	622,368	0	For
State Street	577,221	10,120	For
Advisors' Inner Circle Fund II	517,000	0	For
Fiera Capital Corp	0	514,810	Against
Bellevue Group AG	0	502,286	Against
BAILLIE GIFFORD & CO LTD	487,434	0	For
Global X	437,473	16,212	For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	0	425,994	Against
MFS	0	425,994	Against
Champlain Investment Partners, LLC	404,962	0	For
Fidelity	378,280	18,470	For
Northern Trust	0	395,380	Against
C WorldWide Asset Management Fondsmaeglerselskab A/S	0	375,000	Against
HSBC	0	305,809	Against
JANUS INVESTMENT FUND	295,038	0	For

Showing the 25 largest of 272 asset managers. See all 272 in the interactive database.

2. Election of Class II Directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Antal Desai

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

77% Majority: yes · of votes cast

FOR 77%WITHHELD 23%

FOR: 28,444,121WITHHELD: 8,511,185

PROCEPT BioRobotics Corporation’s own tally for this item (“Elect Director: Antal Desai”): 28,444,121 for, 8,511,185 withheld, per its Form 8-K filed 2026-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 56,897,000 outstanding shares: 49.9% for, 15% withheld (65% of the company cast a for/withheld vote).

The 69 asset managers below cast 100% of the shares they voted on this item FOR (11,365,510 for, 0 against).

FOR 90%10%

FOR: 11,365,510 (90.3%)ABSTAIN: 1,227,329 (9.7%)

Largest asset managers voting on “Election of Class II Directors to serve until 2029 annual meeting of stockholders and until their successors a” at PROCEPT BioRobotics Corporation, 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	4,822,031	39	For
T. Rowe Price	2,477,773	0	For
BlackRock	902,965	0	For
Advisors' Inner Circle Fund II	517,000	0	For
Charles Schwab	457,727	0	For
Global X	453,685	0	For
MFS	0	425,994	Abstain
JANUS INVESTMENT FUND	295,038	0	For
WASATCH FUNDS TRUST	217,744	0	For
Fidelity	186,391	18,470	For
State Street	147,970	98	For
WILLIAM BLAIR FUNDS	0	146,570	Abstain
TIAA	121,954	0	For
Equitable	81,255	39,990	For
Federated Hermes	110,633	0	For
PROFESSIONALLY MANAGED PORTFOLIOS	0	99,120	Abstain
AllianceBernstein	0	86,857	Abstain
Bridge Builder Trust	66,031	0	For
VELA Funds	65,565	0	For
Jackson National	0	56,129	Abstain
Segall Bryant & Hamill Trust	0	55,730	Abstain
First Trust	0	49,738	Abstain
TRUST FOR PROFESSIONAL MANAGERS	48,757	0	For
Lincoln Financial	36,000	12,369	For
New York Life	48,158	0	For

Showing the 25 largest of 69 asset managers. See all 69 in the interactive database.

3. Election of Class II Directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Frederic Moll, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 36,455,610WITHHELD: 499,696

PROCEPT BioRobotics Corporation’s own tally for this item (“Elect Director: Frederic Moll, M.D.”): 36,455,610 for, 499,696 withheld, per its Form 8-K filed 2026-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 56,897,000 outstanding shares: 64% for, 0.9% withheld (65% of the company cast a for/withheld vote).

The 69 asset managers below cast 100% of the shares they voted on this item FOR (12,465,991 for, 0 against).

FOR 99%

FOR: 12,465,991 (99.0%)ABSTAIN: 126,848 (1.0%)

Largest asset managers voting on “Election of Class II Directors to serve until 2029 annual meeting of stockholders and until their successors a” at PROCEPT BioRobotics Corporation, 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	4,822,069	1	For
T. Rowe Price	2,477,773	0	For
BlackRock	902,965	0	For
Advisors' Inner Circle Fund II	517,000	0	For
Charles Schwab	457,727	0	For
Global X	453,685	0	For
MFS	425,994	0	For
JANUS INVESTMENT FUND	295,038	0	For
WASATCH FUNDS TRUST	217,744	0	For
Fidelity	204,861	0	For
State Street	148,068	0	For
WILLIAM BLAIR FUNDS	146,570	0	For
TIAA	121,954	0	For
Equitable	81,255	39,990	For
Federated Hermes	110,633	0	For
PROFESSIONALLY MANAGED PORTFOLIOS	99,120	0	For
AllianceBernstein	0	86,857	Abstain
Bridge Builder Trust	66,031	0	For
VELA Funds	65,565	0	For
Jackson National	56,129	0	For
Segall Bryant & Hamill Trust	55,730	0	For
First Trust	49,738	0	For
TRUST FOR PROFESSIONAL MANAGERS	48,757	0	For
Lincoln Financial	48,369	0	For
New York Life	48,158	0	For

Showing the 25 largest of 69 asset managers. See all 69 in the interactive database.

4. Election of Class II Directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Mary Garrett

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%WITHHELD 21%

FOR: 29,150,610WITHHELD: 7,804,696

PROCEPT BioRobotics Corporation’s own tally for this item (“Elect Director: Mary Garrett”): 29,150,610 for, 7,804,696 withheld, per its Form 8-K filed 2026-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 56,897,000 outstanding shares: 51.2% for, 14% withheld (65% of the company cast a for/withheld vote).

The 69 asset managers below cast 100% of the shares they voted on this item FOR (11,308,690 for, 0 against).

FOR 90%10%

FOR: 11,308,690 (89.8%)ABSTAIN: 1,284,149 (10.2%)

Largest asset managers voting on “Election of Class II Directors to serve until 2029 annual meeting of stockholders and until their successors a” at PROCEPT BioRobotics Corporation, 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	4,819,030	3,041	For
T. Rowe Price	2,477,773	0	For
BlackRock	902,965	0	For
Advisors' Inner Circle Fund II	517,000	0	For
Charles Schwab	457,727	0	For
Global X	437,473	16,212	For
MFS	0	425,994	Abstain
JANUS INVESTMENT FUND	295,038	0	For
WASATCH FUNDS TRUST	217,744	0	For
Fidelity	186,391	18,470	For
State Street	147,970	98	For
WILLIAM BLAIR FUNDS	0	146,570	Abstain
TIAA	121,954	0	For
Equitable	81,255	39,990	For
Federated Hermes	110,633	0	For
PROFESSIONALLY MANAGED PORTFOLIOS	0	99,120	Abstain
AllianceBernstein	0	86,857	Abstain
Bridge Builder Trust	66,031	0	For
VELA Funds	65,565	0	For
Jackson National	0	56,129	Abstain
Segall Bryant & Hamill Trust	0	55,730	Abstain
First Trust	0	49,738	Abstain
TRUST FOR PROFESSIONAL MANAGERS	48,757	0	For
Lincoln Financial	36,000	12,369	For
New York Life	48,158	0	For

Showing the 25 largest of 69 asset managers. See all 69 in the interactive database.

5. Ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026.

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 67 asset managers below cast 100% of the shares they voted on this item FOR (12,577,839 for, 0 against).

FOR: 12,577,839 (100.0%)

Largest asset managers voting on “Ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting fi” at PROCEPT BioRobotics Corporation, 2025-2026
Asset manager	For	Vote
Vanguard	4,822,070	For
T. Rowe Price	2,477,773	For
BlackRock	902,965	For
Advisors' Inner Circle Fund II	517,000	For
Charles Schwab	457,727	For
Global X	453,685	For
MFS	425,994	For
JANUS INVESTMENT FUND	295,038	For
WASATCH FUNDS TRUST	217,744	For
Fidelity	204,861	For
State Street	148,068	For
WILLIAM BLAIR FUNDS	146,570	For
TIAA	121,954	For
Equitable	121,245	For
Federated Hermes	110,633	For
PROFESSIONALLY MANAGED PORTFOLIOS	99,120	For
AllianceBernstein	86,857	For
Bridge Builder Trust	66,031	For
VELA Funds	65,565	For
Jackson National	56,129	For
Segall Bryant & Hamill Trust	55,730	For
First Trust	49,738	For
TRUST FOR PROFESSIONAL MANAGERS	48,757	For
Lincoln Financial	48,369	For
New York Life	48,158	For

Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.

Largest PROCEPT BioRobotics Corporation shareholders voting in 2025-2026

Ranked by the number of PROCEPT BioRobotics Corporation shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 56,897,000 shares outstanding at the time of that meeting.

Top PROCEPT BioRobotics Corporation shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	T. Rowe Price	11.17%
2	Vanguard	9.30%
3	BNP Paribas Asset Management Holding S.A.	5.30%
4	BlackRock	4.86%
5	MACKENZIE FINANCIAL CORP	3.02%
6	Chicago Capital, LLC	2.53%
7	Charles Schwab	1.61%
8	Artisan	1.40%
9	MIROVA	1.28%
10	Wellington	1.12%

Reported PROCEPT BioRobotics Corporation ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

PROCEPT BioRobotics Corporation beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
BlackRock	7.67%	13F
BNP Paribas Asset Management Holding S.A.	5.44%	13G
Reza Zadno, Ph.D.	2.95%	DEF14A
State Street	2.69%	13F
FMR (Fidelity)	2.57%	13F
Point72	2.00%	13F
Frederic Moll, M.D.	1.67%	DEF14A
Wellington Management	1.51%	13F
Morgan Stanley	1.48%	13F
T. Rowe Price	1.07%	13F

Percentages above are of 56,897,000 shares outstanding, as reported by PROCEPT BioRobotics Corporation on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PROCEPT BioRobotics Corporation’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At PROCEPT BioRobotics Corporation's shareholder meeting held 2026-06-09, in the 2025-2026 proxy season, 272 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,292 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on a non-binding advisory basis, of the compensation of the Company's named executive… — FOR was 73% of the votes cast (FOR divided by FOR plus WITHHELD, because this ballot offered only for and withhold; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: PROCEPT BioRobotics Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-10.

PROCEPT BioRobotics Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).